Mylan’s EpiPen profits are 60 percent more than it told Congress The(01)

Mylan’s EpiPen profits are 60 percent more than it told Congress The(01)


Image gallery: Epipen Company Tells Congress Profits Are 60 Percent Lower Than Actual Amount

Congress Presses Pharmaceutical Company to Explain Surge in Cost of Mylan’s EpiPen profits are 60 percent more than it told Congress The Mylan EpiPen profits are 60 percent higher than it told Congress Mylan’s EpiPen Pretax Profits 60 Higher Than Number Told to Congress WSJ Drug company stung by criticism of 'outrageous' EpiPen price rises